Effect of Linagliptin on Glycemic Control in Chinese Patients with Newly-Diagnosed, Drug-Naïve Type 2 Diabetes Mellitus: A Randomized Controlled Trial

BACKGROUND: This study aimed to evaluate the efficacy and safety of linagliptin (a novel dipeptidyl peptidase (DPP)-4 inhibitor) on glucose metabolism and β-cell function in Chinese patients with newly-diagnosed, drug-naïve type 2 diabetes mellitus (T2DM). MATERIAL/METHODS: Newly-diagnosed and drug-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Wenjun, Li, Ying, Chen, Xiong, Lin, Dini, Xiang, Songying, Shen, Feixia, Gu, Xuemei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2015
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571530/
https://www.ncbi.nlm.nih.gov/pubmed/26350766
http://dx.doi.org/10.12659/MSM.894026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571530/
https://www.ncbi.nlm.nih.gov/pubmed/26350766
http://dx.doi.org/10.12659/MSM.894026

Ejemplares similares